Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Toxins|March 6, 2021
The Central Effects of Botulinum Toxin in Dystonia and SpasticityPavel Hok, Tomáš Veverka, Petr Hluštík, et al.Neuro Endocrinology Letters|May 29, 2012
Coronary artery disease is not associated with stroke recurrenceMichal Kováčik, Štefan Madarász, Michal Král, et al.Medicine|June 23, 2021
Cortical somatosensory processing after botulinum toxin therapy in post-stroke spasticityTomáš Veverka, Petr Hluštík, Pavel Otruba, et al.Journal of the Neurological Sciences|September 27, 2014
Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movementTomáš Veverka, Petr Hluštík, Pavel Hok, et al.Journal of the Neurological Sciences|March 6, 2016
Sensorimotor modulation by botulinum toxin A in post-stroke arm spasticity: Passive hand movementTomáš Veverka, Petr Hluštík, Pavel Hok, et al.Frontiers in Neurology|May 31, 2019
Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper LimbTomáš Veverka, Pavel Hok, Pavel Otruba, et al.Journal of the Neurological Sciences|February 24, 2023
Interhemispheric parietal cortex connectivity reflects improvement in post-stroke spasticity due to treatment with botulinum toxin-ATomáš Veverka, Pavel Hok, Markéta Trnečková, et al.International Journal of Stroke : Official Journal of the International Stroke Society|August 28, 2015
Posterior vs. anterior circulation infarction: demography, outcomes, and frequency of hemorrhage after thrombolysisTomáš Dorňák, Michal Král, Martin Hazlinger, et al.Journal of the Neurological Sciences|June 13, 2012
BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic strokeTomáš Veverka, Petr Hluštík, Zuzana Tomášová, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 30, 2018
Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical ExperienceDaniel Šaňák, Stanislava Jakubíček, David Černík, et al.Pageof 3